Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide Concentration

Ashley M. Hopkins, Mahin Moghaddami, David J. R. Foster, Susanna M. Proudman, Richard N. Upton and Michael D. Wiese
Drug Metabolism and Disposition January 2017, 45 (1) 8-16; DOI: https://doi.org/10.1124/dmd.116.071985
Ashley M. Hopkins
University of South Australia, Australian Centre for Pharmacometrics (A.M.H., D.J.R.F., R.N.U.) and Sansom Institute for Health Research (A.M.H., D.J.R.F., R.N.U., M.D.W), School of Pharmacy and Medical Sciences, Adelaide, South Australia, Australia; Arthritis Research Laboratory, Hanson Institute, SA Pathology, Adelaide, South Australia, Australia (M.M.); Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia (M.M., S.M.P.); and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia (S.M.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahin Moghaddami
University of South Australia, Australian Centre for Pharmacometrics (A.M.H., D.J.R.F., R.N.U.) and Sansom Institute for Health Research (A.M.H., D.J.R.F., R.N.U., M.D.W), School of Pharmacy and Medical Sciences, Adelaide, South Australia, Australia; Arthritis Research Laboratory, Hanson Institute, SA Pathology, Adelaide, South Australia, Australia (M.M.); Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia (M.M., S.M.P.); and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia (S.M.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. R. Foster
University of South Australia, Australian Centre for Pharmacometrics (A.M.H., D.J.R.F., R.N.U.) and Sansom Institute for Health Research (A.M.H., D.J.R.F., R.N.U., M.D.W), School of Pharmacy and Medical Sciences, Adelaide, South Australia, Australia; Arthritis Research Laboratory, Hanson Institute, SA Pathology, Adelaide, South Australia, Australia (M.M.); Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia (M.M., S.M.P.); and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia (S.M.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanna M. Proudman
University of South Australia, Australian Centre for Pharmacometrics (A.M.H., D.J.R.F., R.N.U.) and Sansom Institute for Health Research (A.M.H., D.J.R.F., R.N.U., M.D.W), School of Pharmacy and Medical Sciences, Adelaide, South Australia, Australia; Arthritis Research Laboratory, Hanson Institute, SA Pathology, Adelaide, South Australia, Australia (M.M.); Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia (M.M., S.M.P.); and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia (S.M.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard N. Upton
University of South Australia, Australian Centre for Pharmacometrics (A.M.H., D.J.R.F., R.N.U.) and Sansom Institute for Health Research (A.M.H., D.J.R.F., R.N.U., M.D.W), School of Pharmacy and Medical Sciences, Adelaide, South Australia, Australia; Arthritis Research Laboratory, Hanson Institute, SA Pathology, Adelaide, South Australia, Australia (M.M.); Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia (M.M., S.M.P.); and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia (S.M.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Wiese
University of South Australia, Australian Centre for Pharmacometrics (A.M.H., D.J.R.F., R.N.U.) and Sansom Institute for Health Research (A.M.H., D.J.R.F., R.N.U., M.D.W), School of Pharmacy and Medical Sciences, Adelaide, South Australia, Australia; Arthritis Research Laboratory, Hanson Institute, SA Pathology, Adelaide, South Australia, Australia (M.M.); Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia (M.M., S.M.P.); and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia (S.M.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Leflunomide’s active metabolite teriflunomide inhibits dihydro-oroate dehydrogenase, an enzyme essential to proliferation of T lymphocytes. As teriflunomide must reach the target site to have this effect, this study assessed the distribution of teriflunomide into T lymphocytes, as intracellular concentrations may be a superior response biomarker to plasma concentrations. CD3 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) were used to extract CD3+ T cells from the peripheral blood of patients with rheumatoid arthritis who were taking a stable dose of leflunomide. Unbound plasma and intra-CD3+ T cell teriflunomide concentrations were quantified using liquid chromatography–mass spectrometry. Concentration (log transformed) and partition differences were assessed through paired Student t tests. Sixteen patients provided plasma steady-state teriflunomide samples, and eight provided a sample 6–12 weeks later. At time-point one, the geometric mean teriflunomide concentration (range) in CD3+ T cells was 18.12 μg/L (6.15–42.26 μg/L) compared with 69.75 μg/L (32.89–263.1 μg/L) unbound in plasma (P < 0.001). The mean partition coefficient (range) for unbound plasma teriflunomide into CD3+ T cells was 0.295 (0.092–0.632), which was significantly different from unity (P < 0.001). The median (range) change in teriflunomide concentration between the two time points was 14% (−10% to 40%) in unbound plasma and −29% (−69 to 138%) for CD3+ T cells. Because teriflunomide concentrations in CD3+ T cells were lower and displayed a higher intraindividual variability than the unbound plasma concentrations, its applicability as a therapeutic drug-monitoring marker may be limited.

Footnotes

    • Received June 6, 2016.
    • Accepted October 13, 2016.
  • dx.doi.org/10.1124/dmd.116.071985.

  • Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 45 (1)
Drug Metabolism and Disposition
Vol. 45, Issue 1
1 Jan 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Intracellular CD3+ T Lymphocyte Teriflunomide Concentration Is Poorly Correlated with and Has Greater Variability Than Unbound Plasma Teriflunomide Concentration
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

CD3+ T Cell Teriflunomide Concentration Quantification

Ashley M. Hopkins, Mahin Moghaddami, David J. R. Foster, Susanna M. Proudman, Richard N. Upton and Michael D. Wiese
Drug Metabolism and Disposition January 1, 2017, 45 (1) 8-16; DOI: https://doi.org/10.1124/dmd.116.071985

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

CD3+ T Cell Teriflunomide Concentration Quantification

Ashley M. Hopkins, Mahin Moghaddami, David J. R. Foster, Susanna M. Proudman, Richard N. Upton and Michael D. Wiese
Drug Metabolism and Disposition January 1, 2017, 45 (1) 8-16; DOI: https://doi.org/10.1124/dmd.116.071985
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Series-Compartment Models of Hepatic Elimination
  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics